Predictive value of lung function below the normal range and respiratory symptoms for progression of chronic obstructive pulmonary disease

被引:17
作者
Albers, M. [1 ]
Schermer, T. [1 ]
Heijdra, Y. [1 ]
Molema, J. [1 ]
Akkermans, R. [1 ]
van Weel, C. [1 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Primary Care, NL-6500 HB Nijmegen, Netherlands
关键词
D O I
10.1136/thx.2006.068007
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Chronic obstructive pulmonary disease ( COPD) is an insidiously starting disease. Early detection has high priority because of the possibility of early implementation of smoking cessation interventions. An evidence based model for case finding of COPD is not yet available. Objective: To describe the early development of COPD, and to assess the predictive value of early signs (respiratory symptoms, lung function below the normal range, reversibility). Design and methods: In a prospective study, based in general practice, formerly undiagnosed subjects (n = 464) were assessed at baseline and at 5 years for respiratory symptoms and pulmonary function. Odds ratios for early signs were calculated ( adjusted for age, gender, pack-years at baseline and smoking behaviour during follow-up), and defined as possible indicators of disease progression. Results: Over a 5 year period, the percentage of subjects with obstruction increased from 7.5% (n = 35) at baseline to 24.8% (n = 115) at 5 years. The presence of mild early signs and lung function below the normal range at baseline were related to an increased risk of developing mild to moderate COPD (GOLD I: OR 1.87 (95% CI 1.22 to 2.87); GOLD II: OR 2.08 (95% CI 1.29 to 3.37) to 2.54 (95% CI 1.25 to 5.19)) at 5 years. Conclusion: Lung function below the normal range and early respiratory signs predict the development and progression of COPD.
引用
收藏
页码:201 / 207
页数:7
相关论文
共 37 条
[1]   Efficacy of inhaled steroids in undiagnosed subjects at high risk for COPD - Results of the detection, intervention, and monitoring of COPD and asthma program [J].
Albers, M ;
Schermer, T ;
van den Boom, G ;
Akkermans, R ;
van Schayck, C ;
van Herwaarden, C ;
van Weel, C .
CHEST, 2004, 126 (06) :1815-1824
[2]  
ALBERS M, 2002, BMJ-BRIT MED J, V324, P1370
[4]  
BOOM GVD, 1999, ASTHMA GEN PRACT, V7, P3
[5]   Office spirometry significantly improves early detection of COPD in general practice - The DIDASCO study [J].
Buffels, J ;
Degryse, J ;
Heyrman, J ;
Decramer, M .
CHEST, 2004, 125 (04) :1394-1399
[6]   Population impact of different definitions of airway obstruction [J].
Celli, BR ;
Halbert, RJ ;
Isonaka, S ;
Schau, B .
EUROPEAN RESPIRATORY JOURNAL, 2003, 22 (02) :268-273
[7]   The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease [J].
Celli, BR ;
Cote, CG ;
Marin, JM ;
Casanova, C ;
de Oca, MM ;
Mendez, RA ;
Pinto Plata, V ;
Cabral, HJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (10) :1005-1012
[8]   Undiagnosed airflow obstruction: prevalence and implications [J].
Coultas, DB ;
Mapel, DW .
CURRENT OPINION IN PULMONARY MEDICINE, 2003, 9 (02) :96-103
[9]   The health impact of undiagnosed airflow obstruction in a national sample of United States adults [J].
Coultas, DB ;
Mapel, D ;
Gagnon, R ;
Lydick, E .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 164 (03) :372-377
[10]   An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages [J].
de Marco, R ;
Accordini, S ;
Cerveri, I ;
Corsico, A ;
Sunyer, J ;
Neukirch, F ;
Künzli, N ;
Leynaert, B ;
Janson, C ;
Gislason, T ;
Vermeire, P ;
Svanes, C ;
Anto, JM ;
Burney, P .
THORAX, 2004, 59 (02) :120-125